Loading organizations...
Key people at Palkon Capital.
Palkon Capital was founded in 2013 by Shaheen Wirk (Founder and Portfolio Manager).
Palkon Capital Management specializes in investing in innovative private and public life sciences companies, serving as a dedicated capital manager. The firm strategically offers portfolio management, financial planning, and investment advisory services, aiming to cultivate long-term partnerships with the management teams of its portfolio companies. Its approach centers on identifying and supporting advancements within the life sciences sector.
The firm was founded in 2013 by Shaheen Wirk, who also serves as its Portfolio Manager. Wirk established Palkon Capital Management with the insight that focused investment and advisory support could significantly accelerate the growth and impact of promising life sciences ventures. This origin reflects a commitment to leveraging capital and expertise to drive progress in critical scientific and medical fields.
Palkon Capital Management primarily serves a client base within the United States, collaborating with companies and investors seeking to navigate and capitalize on opportunities in the life sciences. The company’s vision is to foster innovation and build enduring value by partnering with exceptional teams, thereby contributing to the development of groundbreaking solutions in health and biotechnology.
Key people at Palkon Capital.
Palkon Capital has 1 tracked investment across 1 company. The latest tracked deal is $74.0M Series B in Tvardi Therapeutics in June 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 23, 2021 | Tvardi Therapeutics | $74.0M Series B | 683 Capital Management, ArrowMark Partners, Palkon Capital, Jamie Mcnab | Sporos Bioventures |
Palkon Capital was founded in 2013 by Shaheen Wirk (Founder and Portfolio Manager).